William Dull

William brings more than 30 years of senior level P&L leadership as a life science executive. As an accomplished entrepreneur, he has built, developed and led high-performing integrated teams and partnerships from early-stage research and development to successful domestic and international commercialization.

He has built businesses and advanced value propositions to deliver significant revenue growth for start-up and mid-sized companies.  William has extensive hospital-based product experience. 

William serves as Renovia’s Chief Commercial Officer overseeing commercial launch of Renovia’s platform of App-based digital therapeutics and diagnostic devices. 

Before joining Renovia, William was Vice President of Aegerion Pharmaceuticals where he developed innovative solutions that solved complex patient problems. At Aegerion he led global strategic marketing, commercial operations, consumer engagement and training in the launch of two therapeutic brands.

Prior to joining Aegerion, William held global executive positions of increasing responsibilities in operations, strategic planning, sales and marketing, patient advocacy and new product commercialization for Cytovance, Johnson & Johnson, Transkaryotic Therapies and Genentech. 

William holds a Bachelor of Science degree in Business Administration from Georgia State University.